CHANGE IN CARDIOMETABOLIC RISK MARKERS FOLLOWING
SWITCH TO INTEGRASE INHIBITORS DIFFERS BY SEX
CROI 2025 SF March 9-12
Cecile D. Lahiri1, C. Christina Mehta1, Qian Yang1, Julie B. Dumond2, Maria L. Alcaide3, Frank Palella4, Jordan E. Lake5,
Leah H. Rubin6, Audrey L. French7, Seble Kassaye8, Michael Augenbran9, Anjali Sharma10, Igho Ofotokun1,
Anandi N. Sheth1, Jessica A. Alvarez11
